Clinical Trial

A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to compare the bioavailability and adhesion of a generic Selegiline transdermal system (TDS) against the marketed comparator (EMSAM®) in healthy volunteers. Systemic and local safety and tolerability will be also observed and evaluated.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-02
minor Completion moved earlier: 2026-07-29 -> 2026-06-16 2026-07-02
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-29
Trial Details
NCT Number NCT07571824
Lead Sponsor Corium Innovations, Inc.
Conditions Healthy Adult Participants
Enrollment 92 participants
Start Date 2026-03-23
Primary Completion 2026-06-16 (estimated)
Study Completion 2026-06-16 (estimated)
Updated on ClinicalTrials.gov 2026-07-01